×
Amplifon S.p.A EBIT 2019-2025 | AMFPF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Amplifon S.p.A ebit from 2019 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Amplifon S.p.A EBIT 2019-2025 | AMFPF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Amplifon S.p.A ebit from 2019 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.4B
CVS Health (CVS)
$92.8B
Elevance Health (ELV)
$71.8B
Cencora (COR)
$56.5B
DiDi Global (DIDIY)
$27.5B
Labcorp Holdings (LH)
$23.1B
Natera (NTRA)
$23.1B
BioMerieux (BMXMF)
$16.6B
EUROFINS SCIENT (ERFSF)
$14.6B
ICON (ICLR)
$14.4B
Medpace Holdings (MEDP)
$13.4B
CochLear (CHEOY)
$12.9B
Solventum (SOLV)
$12.7B
Viatris (VTRS)
$12.3B
Caris Life Sciences,�Inc (CAI)
$10.8B
Revvity (RVTY)
$10.5B
Avantor (AVTR)
$9.2B
Charles River Laboratories (CRL)
$8B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.7B
Bausch + Lomb (BLCO)
$5.2B
Sotera Health (SHC)
$4.6B
BrightSpring Health Services (BTSG)
$4.2B
GeneDx Holdings (WGS)
$3.7B
Alignment Healthcare (ALHC)
$3.2B
Concentras Parent (CON)
$3.1B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B
Premier (PINC)
$2.1B
KindlyMD (NAKA)
$2B